Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-IODO-4-NITROTOLUENE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

52488-29-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 52488-29-6 Structure
  • Basic information

    1. Product Name: 3-IODO-4-NITROTOLUENE
    2. Synonyms: 3-IODO-4-NITROTOLUENE;3-Iodo-4-nitrotoluene,97%;2-iodo-4-methyl-1-nitrobenzene;3-Iodo-4-nitrotoluene 97%
    3. CAS NO:52488-29-6
    4. Molecular Formula: C7H6INO2
    5. Molecular Weight: 263.03
    6. EINECS: N/A
    7. Product Categories: Aromatic Hydrocarbons (substituted) & Derivatives;Nitro Compounds;Nitrogen Compounds;Organic Building Blocks;Building Blocks;Chemical Synthesis;Nitro Compounds;Nitrogen Compounds;Organic Building Blocks
    8. Mol File: 52488-29-6.mol
  • Chemical Properties

    1. Melting Point: 18-20 °C
    2. Boiling Point: 295 °C
    3. Flash Point: >230 °F
    4. Appearance: Yellow/Low Melting Crystalline Mass or Liquid
    5. Density: 1.862 g/mL at 25 °C
    6. Vapor Pressure: 0.00115mmHg at 25°C
    7. Refractive Index: n20/D 1.637
    8. Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
    9. Solubility: N/A
    10. CAS DataBase Reference: 3-IODO-4-NITROTOLUENE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3-IODO-4-NITROTOLUENE(52488-29-6)
    12. EPA Substance Registry System: 3-IODO-4-NITROTOLUENE(52488-29-6)
  • Safety Data

    1. Hazard Codes: Xn,N
    2. Statements: 22-50
    3. Safety Statements: 60-61
    4. RIDADR: UN 3082 9/PG 3
    5. WGK Germany: 2
    6. RTECS:
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 52488-29-6(Hazardous Substances Data)

52488-29-6 Usage

Chemical Properties

yellow low melting crystalline mass or liquid

Check Digit Verification of cas no

The CAS Registry Mumber 52488-29-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,4,8 and 8 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 52488-29:
(7*5)+(6*2)+(5*4)+(4*8)+(3*8)+(2*2)+(1*9)=136
136 % 10 = 6
So 52488-29-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H6INO2/c1-5-2-3-7(9(10)11)6(8)4-5/h2-4H,1H3

52488-29-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (659320)  3-Iodo-4-nitrotoluene  97%

  • 52488-29-6

  • 659320-5G

  • 983.97CNY

  • Detail
  • Aldrich

  • (659320)  3-Iodo-4-nitrotoluene  97%

  • 52488-29-6

  • 659320-25G

  • 3,627.00CNY

  • Detail

52488-29-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Iodo-4-nitrotoluene

1.2 Other means of identification

Product number -
Other names 2-iodo-4-methyl-1-nitrobenzene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:52488-29-6 SDS

52488-29-6Relevant articles and documents

The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB1 Receptor Positive Allosteric Modulators

Tseng, Chih-Chung,Baillie, Gemma,Donvito, Giulia,Mustafa, Mohammed A.,Juola, Sophie E.,Zanato, Chiara,Massarenti, Chiara,Dall'Angelo, Sergio,Harrison, William T. A.,Lichtman, Aron H.,Ross, Ruth A.,Zanda, Matteo,Greig, Iain R.

supporting information, p. 5049 - 5062 (2019/05/28)

The first generation of CB1 positive allosteric modulators (e.g., ZCZ011) featured a 3-nitroalkyl-2-phenyl-indole structure. Although a small number of drugs include the nitro group, it is generally not regarded as being "drug-like", and this is particularly true for aliphatic nitro groups. There are very few case studies where an appropriate bioisostere replaced a nitro group that had a direct role in binding. This may be indicative of the difficulty of replicating its binding interactions. Herein, we report the design and synthesis of ligands targeting the allosteric binding site on the CB1 cannabinoid receptor, in which a CF3 group successfully replaced the aliphatic NO2. In general, the CF3-bearing compounds were more potent than their NO2 equivalents and also showed improved in vitro metabolic stability. The CF3 analogue (1) with the best balance of properties was selected for further pharmacological evaluation. Pilot in vivo studies showed that (±)-1 has similar activity to (±)-ZCZ011, with both showing promising efficacy in a mouse model of neuropathic pain.

Synthetic method of aryl halide taking aryl carboxylic acid as raw material

-

Paragraph 0091, (2018/01/03)

A synthetic method of an aryl halide taking aryl carboxylic acid as a raw material is characterized in that a corresponding aryl halide is formed by carrying out substitution reaction on an aryl carboxylic acid compound and haloid salt MX in an organic solvent under the condition that oxygen, a silver catalyst, a copper additive and a bidentate nitrogen ligand exist, wherein M in MX represents alkali metal or alkaline earth metal, and X represents F, Cl, Br or I. Compared with a conventional aryl halide synthetic method, the synthetic method disclosed by the invention has the obvious advantages that reaction raw materials (comprising aryl carboxylic acid and MX) are cheap and easy to obtain, the using amount of a metal catalyst is small, pollution to the environment when the oxygen is used as an oxidant is the smallest, good tolerance to various functional groups on an aromatic ring is obtained, the yield is high, and the like. The synthetic method disclosed by the invention can be widely applied to synthesis in the fields of medicine, materials, natural products and the like in industry and academia.

Decarboxylative Halogenation and Cyanation of Electron-Deficient Aryl Carboxylic Acids via Cu Mediator as Well as Electron-Rich Ones through Pd Catalyst under Aerobic Conditions

Fu, Zhengjiang,Li, Zhaojie,Song, Yuanyuan,Yang, Ruchun,Liu, Yanzhu,Cai, Hu

, p. 2794 - 2803 (2016/04/26)

Simple strategies for decarboxylative functionalizations of electron-deficient benzoic acids via using Cu(I) as promoter and electron-rich ones by employing Pd(II) as catalyst under aerobic conditions have been established, which lead to smooth synthesis of aryl halides (-I, Br, and Cl) through the decarboxylative functionalization of benzoic acids with readily available halogen sources CuX (X = I, Br, Cl), and easy preparation of benzonitriles from decarboxylative cyanation of aryl carboxylic acids with nontoxic and low-cost K4Fe(CN)6 under an oxygen atmosphere for the first time.

Highly stereoselective 7-endo-trig /ring contraction cascade to construct pyrrolo[1,2- a ]quinoline derivatives

Li, Xinyu,Li, Cheng,Zhang, Wenjing,Lu, Xiang,Han, Shiqing,Hong, Ran

supporting information; experimental part, p. 1696 - 1699 (2010/09/05)

With the cooperation of Cram's phenonium ion, a novel cascade reaction was illustrated to construct pyrrolo[1,2-a]quinolines as a sole diastereoisomer in good to excellent yields. Preliminary mechanistic studies revealed that the γ-lactam ring and electron-rich arene are important driving forces for ring contraction.

Indenylacetic acid compounds

-

, (2008/06/13)

4, 5, 6 or 7 Aryl substituted indenyl acetic acids and pharmaceutically acceptable salts, amides and esters thereof. The 4, 5, 6 or 7 aryl substituted indenyl acetic acids have anti-inflammatory, anti-pyretic and analgesic activity. The invention also includes methods for the preparation of these compounds, pharmaceutical compositions and methods of treating inflammation by administering these particular compounds to patients.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 52488-29-6